BPC-157: what does the evidence actually show?
BPC-157 has broad preclinical research interest, but the human evidence question remains unresolved. Here is what the evidence actually shows.
Research Hub
clinical trial
VITAL-H: the $38 million human trial that could finally prove longevity drugs work
VITAL-H is a $38 million federally funded trial testing rapamycin, semaglutide, and dapagliflozin in 700–1,000 healthy adults aged 60–65. Here’s what it’s measuring and why it matters.